We hereby apply the approach of photoacoustic chemical
imaging,
performing an in vivo chemical analysis that is spatially resolved
(200 μm) and in real time, to predict a given tumor’s
response to therapy. Using triple negative breast cancer as a model,
we took photoacoustic images of tumors’ oxygen distributions
in patient-derived xenografts (PDXs) in mice using biocompatible,
oxygen-sensitive tumor-targeted chemical contrast nanoelements (nanosonophores),
which function as contrast agents for photoacoustic imaging. Following
radiation therapy, we established a quantitatively significant correlation
between the spatial distribution of the initial oxygen levels in the
tumor and its spatial distribution of the therapy’s efficacy:
the lower the local oxygen, the lower the local radiation therapy
efficacy. We thus provide a simple, noninvasive, and inexpensive method
to both predict the efficacy of radiation therapy for a given tumor
and identify treatment-resistant regions within the tumor’s
microenvironment.